Share Name Share Symbol Market Type Share ISIN Share Description
Horizon Discovery Group Plc LSE:HZD London Ordinary Share GB00BK8FL363 ORD 1P
  Price Change % Change Share Price Shares Traded Last Trade
  0.00 0.0% 184.50 0.00 01:00:00
Bid Price Offer Price High Price Low Price Open Price
184.50 185.00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 58.25 -11.51 -3.10 291
Last Trade Time Trade Type Trade Size Trade Price Currency
- O 0 184.50 GBX

Horizon Discovery (HZD) Latest News

More Horizon Discovery News
Horizon Discovery Investors    Horizon Discovery Takeover Rumours

Horizon Discovery (HZD) Discussions and Chat

Horizon Discovery Forums and Chat

Date Time Title Posts
15/1/202112:43Horizon Discovery Ltd - Genomic translation 1,466
04/10/201812:17Horizon Discovery (HZD) One to Watch -
23/7/201415:43Alan Green says to BUY and HOLD in Horizon-

Add a New Thread

Horizon Discovery (HZD) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Horizon Discovery trades in real-time

Horizon Discovery (HZD) Top Chat Posts

Horizon Discovery Daily Update: Horizon Discovery Group Plc is listed in the Health Care Equipment & Services sector of the London Stock Exchange with ticker HZD. The last closing price for Horizon Discovery was 184.50p.
Horizon Discovery Group Plc has a 4 week average price of 0p and a 12 week average price of 0p.
The 1 year high share price is 200p while the 1 year low share price is currently 88.40p.
There are currently 157,976,096 shares in issue and the average daily traded volume is 0 shares. The market capitalisation of Horizon Discovery Group Plc is £291,465,897.12.
gnnmartin: I don't follow the fine detail of these 2.9 & 8.3 disclosures. I assume to begin with the buyers hoped for a bid, but again, I assume that is looking unlikely. However, there is still the hope for those buying in that they will upset the scheme of arrangement. The danger is that if the scheme is upset, Horizon & Perkin Elmer will call it all off: I think that is unlikely. The hope is that that Horizon & Perkin will sweeten the terms by (say) 10% in an effort to get it through. I intend to do nothing, and see what happens. The market price is higher than the scheme price, but not by all that much, and you will get the offer price (lower than the market price), and you will pay broker's fees.
bouleversee: Yes, I understand that. I meant I was dithering over whether to sell them now rather than wait for the deal to go through at a lower price than I could get now, assuming it does go through. I see the share price was 200 first thing this a.m., now 191. Investigate issues these reports daily; this is today's, which shows a larger number than yesterday's. What exactly does this mean? That HZD have issued more shares or they have bought more? If they had enough unconditional support to secure the vote, surely they wouldn't need to do the latter, would they? Why is anyone they prepared to pay more now than they will get (or have to pay out) when the deal completes? I'd expect the share price to be lower than the t/o price if it's a done deal. Is there another bidder in the wings or is there a chance that the deal won't go through? Have they already got sufficient committed acceptances, in which case why does the share price keep going up? Or is it shorters having to buy back at a high price? All very confusing. Edit: I left out the report: "In accordance with Rule 2.9 of the City Code on Takeovers and Mergers, Horizon confirms that, on 25 November 2020 (the date of this announcement), it has 158,310,476 ordinary shares of £0.01 each in issue and admitted to trading on AIM. The International Securities Identification Number ("ISIN") for the Company's ordinary shares is GB00BK8FL363."
bouleversee: I'm still holding and debating what to do. I don't know whatto make of s.p movements. Numis seems to be trading in HZD but who are they selling to?
thewheeliedealer: Hi all, My mate Peter @Conkers3 and myself did a ‘Twin Petes Investing’ Podcast a few days ago and part of our discussion includes HZD and how we deal with Takeover situations. We also chatted about loads of other Stocks and Ideas for research with a particular slant on potential Takeover Targets, and the outlook for Markets and as usual a fair bit of educational stuff with regards to Investing. Anyway, if you use Apple, Audioboom, Overcast or Spotify you can find it under the 'Conkers Corner' Channel (you want Podcast TPI 35) and you can find it on Soundcloud at the link below. I hope you enjoy it and find it useful, Cheers, WD @wheeliedealer hTTps://soundcloud.com/user-479955511/conkers3-wheeliedealer-35-takeovers-500-lockdown-winner-lid-ao-hzd-dddd-crst-lid-fan
halfpenny: HZD have exceeded expectations as we have great news. MERRY XMAS EVERYONE... especially to those who believed in HZD. IXI is another opportunity with fantastic solutions and products.
bouleversee: I don't understand why they are rushing to accept such a low offer. The share price was 268.50 on 14.8.2017. Poor return for shareholders with no dividends either. I see the share price is slightly above the offer price a.t.m. Does that suggest a higher bid might be forthcoming?
bouleversee: Not replicsted in the share price, however.
halfpenny: HZD Q3 R&D project driving benefits. HZD Technology driving business customers with UP Front Payments and Royalty. Edit T Cell features changes cell to become a drug. 20/3O million within next 5 years. News update expected this year. Expect return to normality H2. Cash being managed well. EBITDA should improve H2. Staff turnover 15%. IT costs for new website improves services and quality ISO210007 certified this year. Nasdaq listing being worked on. Operating cash flow still positive. Outlook positive and way of working from home working well. Customers relationships improving to a higher level. Outsourcing with sticky services growing H2. Developing screening market and bio production. Drivers remain strong and growing revenue in H2. Q&A Assumption return to growth H2. Driver Academic customers. Customers returning back to work driving demand. RNAI for Covid research online growing. Bio production a challenge and crystal libraries. Outsourcing And Strong Partnership is benefiting HZD. Expecting to outgrow target market overall. Diagnostics and cell line Engineering should grow rapidly and enquiries increasing rapidly. Enjoy HZD price increases for the rest of 2020 and into 2021. My short term Target £1.30 plus plus plus. Future is BRIGHT..
halfpenny: HZD had a strong finish today. Monday should be fantastic news with HZD being Hot Hot Hot with a £1.30 target...News flow will be great and surprisingly positive for HZD.
kestelmill: I see on Google Finance that they are showing Abcam share prices going back to 1998, 7 years before Abcam's IPO. Total nonsense. Abcam floated at 180p a share (36p after 5:1 share split and have NEVER been below that). Taking a long-term view is great but valuations also have to be reasonable. Today's market cap for HZD is £228M on an share price of 146p. Is this company really worth £228M? If so, on what objective basis? I can't see it myself. No profit to speak of and the company itself has managed revenue growth expectations to single figure % per year. The ONLY bull point I can see around HZD is that they are in the CRISPR market. So far they've failed to capitalise on it in a way that is suggestive of a company that can multiply its value 10-fold, which is what I want from companies I invest in. I did have high hopes for HZD hence my interest.
Horizon Discovery share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
Horizon Di..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210920 14:27:44